相关实验视频

Updated: Jun 30, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

在帕金森病中与Δ-9-四大麻素的短期大麻二醇:一项随机试验

Ying Liu¹, Jacquelyn Bainbridge², Stefan Sillau¹

¹Department of Neurology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, USA.

Movement disorders : official journal of the Movement Disorder Society

|March 15, 2024

概括

这项研究发现,高含量大麻 (CBD) /低-9-四大麻 (THC) 对帕金森病症状没有显著的益处,可能会导致认知和睡眠恶化. 需要进一步的研究.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

大麻使用在帕金森病 (PD) 中很常见.
在PD中大麻疗效和安全性的证据有限.
这项研究调查了PD症状的特定CBD/THC比率.

研究的目的:

在帕金森病 (PD) 中评估高 (CBD) 至低Δ-9-四大麻 (THC) 比例的短期疗效和耐受性.
收集用于更大,更长期的临床试验的初步数据.
评估对运动功能,睡眠,认知和日常生活活动的影响.

主要方法:

一个随机的,安慰剂对照试验在两周内进行.
患有PD的参与者接受了CBD/THC大麻提取物或安慰剂.
测量的主要结果是运动障碍学会统一帕金森病评级表 (MDS-UPDRS) 上的运动分数的变化.

主要成果:

无论是CBD/THC组还是安慰剂组,都显示出运动MDS-UPDRS得分的降低,它们之间没有显著差异.
在几个评估中观察到强烈的安慰剂反应.
在CBD/THC组中,不良事件是轻微的,更频繁,对认知和睡眠有潜在的负面影响.

结论:

短期服用高CBD/低THC的药物并没有对帕金森病的症状有显著的益处.
这项研究受到其短暂的持续时间和实质性的安慰剂效应的限制.
监测大麻素水平的高质量,持续时间较长的试验是必要的,以澄清大麻在PD管理中的作用.

关键词:

帕金森病是帕金森病的一种.在Cannabidiol中使用.大麻大麻大麻大麻大麻大麻大麻大麻

更多相关视频

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...